Concepedia

Christopher M. Sheth

CM

Statistics

Publications

9

Citations

922

H-Index

9

Active since

2007

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Virginia Commonwealth University

Christopher M. Sheth is an author at Center for Drug Evaluation and Research specializing in medicine, pharmacology, and chemotherapy.

Publications per year

2007–2019

9

Publications

9

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 327 citations · Full text

Medicine, Oncology, Pharmacology +17

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Kelly J. Norsworthy, Lola Luo, Vicky Hsu et al. · Clinical Cancer Research · 2019 · 136 citations

Medicine, Hematology, Pharmacology +14

FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Donna Przepiorka, Lola Luo, Sriram Subramaniam et al. · The Oncologist · 2019 · 132 citations · Full text

Medicine, Hematology, Pediatrics +10

FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia

Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam et al. · Clinical Cancer Research · 2019 · 121 citations

Medicine, Oncology, Pharmacology +13

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Emily Y. Jen, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2019 · 91 citations

Medicine, Oncology, Pharmacology +13

1–5 of 9